| No airflow limitation | Airflow limitation | Airflow limitation | Three- groups analysis | No airflow limitation vs. Airflow limitation | |
---|---|---|---|---|---|---|
Mild-to-moderate | Severe | p value | p value | |||
Subject n | 83 | 47 | 37 | 84 | Â | Â |
Mortality | 2.41 | 8.51 | 8.11 | 8.33 | 0.237 | 0.0901 |
Number of acute exacerbations 12 months after enrolment | 1.46 ± 0.83 | 1.72 ± 1.25 | 1.81 ± 0.91 | 1.76 ± 1.10 | 0.0263 | 0.013 |
Number of hospitalizations 24 months after enrolment | 1.10 ± 0.30 | 1.28 ± 0.50 | 1.46 ± 0.84 | 1.36 ± 0.67 | 0.0087 | 0.0016 |
Total number of hospitalizations from enrolment to the end of follow-up | 1.34 ± 0.77 | 1.55 ± 0.97 | 2.11 ± 2.25 | 1.80 ± 1.67 | 0.1336 | 0.0421 |
Exacerbation duration | 8.69 ± 3.78 | 12.77 ± 15.29 | 13.53 ± 12.63 | 13.11 ± 14.03 | 0.0696 | 0.0171 |